Clinical examination of child with parent's consent won't attract offences under Pocso Act, rules Kerala HC
Kochi: Kerala high court has quashed a Pocso case against a 70-year-old paediatrician, holding that the clinical examination of a child, conducted with the consent of a parent or guardian, does not attract offences under the
Pocso Act
.
Justice G Gireesh issued the order while allowing a petition filed by the doctor to quash the case and further proceedings pending before the fast track special court (Pocso Act), Kozhikode.
The allegation was that the petitioner had sexually assaulted a Class X student on two occasions during medical examinations conducted in the presence of her family members. The girl stated that on April 11, 2023, she visited the clinic with her mother for treatment of chest and abdominal pain, during which the doctor allegedly touched her inappropriately.
A similar incident was said to have occurred on April 17, 2024, when she was accompanied by her elder sister.
The sister noticed the victim shivering and later confronted the doctor, which led to the police complaint.
However, upon examining the records, the court noted that neither the mother nor the sister alleged that the medical examination was conducted out of their view. It further observed that it is difficult to believe the petitioner would have acted inappropriately in the close presence of the victim's family members.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Brass Krishna Idols For Prosperity & Protection In Life
Luxeartisanship
Shop Now
Undo
While the victim may have perceived the touch as a 'bad touch', the court held that it would be unsafe to rely on an isolated and possibly misunderstood remark to infer sexual intent.
The court also cited Section 41 of the Pocso Act, which explicitly states that the provisions relating to child sexual offences (Sections 3 to 13) do not apply to medical examinations or treatment carried out with the consent of the child's parent or guardian. Accordingly, the court quashed the case and the further court proceedings against the doctor.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
29 minutes ago
- Time of India
Delhi consumer commission holds lab liable for faulty test report that led to hospitalisation
New Delhi: A faulty lab test report that triggers panic and emergency hospitalisation amounts to a deficiency in service, Delhi State Consumer Disputes Redressal Commission (DSCDRC) has said, asking a private pathology laboratory to compensate the affected customer. In a recent ruling, the state commission upheld the findings of a district consumer forum against Dr Lal Pathlabs and observed that its "grossly erroneous results constitute a failure to perform basic testing accurately, causing undue distress and unnecessary hospitalisation." Dismissing the appeal filed by the lab, the bench of Justice Sangita Dhingra Sehgal (president) and Pinki (member judicial) noted that if "the tests carried out by a laboratory are defective and erroneous, then the diagnosis by the doctor will not be correct, and the patient will not get the proper treatment. The medicines prescribed based on a wrong test report and diagnosis may lead to fatal results for the patient. When a patient's urea levels are reported at more than ten times the normal range, triggering emergency hospitalisation and profound distress, the laboratory cannot retreat behind semantic arguments about its limited role in the diagnostic chain." According to the complainant, on receiving the test report showing abnormally high creatinine levels at 8.39 mg/dl and urea at 189 mg/dl, while the reference range of creatinine is 0.6-1.3 mg/dl and urea at 6-21 mg/dl, the treating doctor directed immediate hospitalisation and further tests while preparing for a procedure. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 임플란트 29만원 이벤트 임플란트 더 알아보기 Undo However, further tests within 24-48 hours revealed normal readings. The same tests were conducted at two other private labs, which also showed the patient's parameters to be within the normal range. "It is to be noted that the medical expenses incurred by the respondent were directly attributable to the appellant's erroneous report, which falsely indicated life-threatening conditions and necessitated emergency hospitalisation ," the commission said. Rejecting the challenge to the award of Rs 3.5 lakh as compensation payable by the laboratory, the state commission pointed out that being "misdiagnosed with life-threatening conditions and undergoing unnecessary hospitalisation constitutes severe psychological trauma. The mental agony and physical suffering cannot be understated. Also, the prolonged litigation justifies litigation costs as a component of compensation. " Dr Lal Pathlabs said that there was no deficiency in service and that the tests were conducted under strict quality control protocols.
Time of India
2 hours ago
- Time of India
Why General Mills discontinued cereals like Medley Crunch and Chocolate Peanut Butter Cheerios
This week, cereal lovers everywhere spotted empty shelf space where beloved Cheerios once stood and must be wondering why. General Mills confirmed that Honey Nut Cheerios Medley Crunch, Chocolate Peanut Butter Cheerios, and the 18‑oz size of Honey Nut Cheerios Minis have officially been discontinued, as reported by ABC News. While the smaller 10.8‑oz minis remain available, these full‑size options have been quietly phased out. On social media, disappointment surged. An anonymous cereal blogger first flagged the pull via Instagram, which spread quickly through Reddit and other fan forums. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Access all TV channels anywhere, anytime Techno Mag Learn More Undo On their website, these products have nearly 200 five‑star reviews for Medley Crunch and some 50 for Chocolate Peanut Butter Cheerios. They have built strong niche followings, but not enough to keep the products afloat, especially as newer, more profitable lines are replacing them. Why did General Mills discontinue the popular breakfast cereals? Live Events Though the company hasn't pinpointed a single reason, its statement cites three key factors: demand declines, ingredient sourcing issues, and ongoing supply‑chain constraints. General Mills clarified it must maintain 'high quality and competitive pricing,' hinting that production costs or complexity may no longer justify these lines amid a shifting portfolio. That shift appears strategic. Recent commentary in Fast Company highlights General Mills' refocus on protein‑enhanced offerings like the new Cheerios Protein cinnamon, strawberry, and cookies‑and‑cream flavors, alongside the revived Frosted Lemon Cheerios for summer. In effect, the company is prizing innovative, health‑and‑wellness aligned cereals over legacy indulgent flavors. Another possible driver is broader dietary pressures. Rising awareness of sugar, fat, and sodium in breakfast cereals, which experienced an 11 % increase in sugar content and may exceed 45 % of the American Heart Association's daily limit in a single bowl, has prompted industry players to reevaluate indulgent SKUs. Discontinuing richer formulas like Chocolate Peanut Butter and Medley Crunch could be a response to healthier consumer trends, regulatory scrutiny, or internal nutrition targets. General Mills continues to reassure fans that discontinued items aren't gone forever. In response to ABC News' query, it stated that much like Frosted Lemon Cheerios, which returned by popular demand, they continue to listen to their fans as they evolve their offerings.
Time of India
2 hours ago
- Time of India
City docs debate new ligament op method
Kolkata: A 31-year-old man underwent arthroscopic ACL (anterior cruciate ligament) reconstruction using a biological augmentation implant, combined with the patient's own tendon graft. Doctors at Woodlands Hospital said this was the first case of a biological implant being used in such a surgery in Bengal. They said recovery takes about three months, compared to the conventional procedure where recovery could take a year. The ACL is a ligament in the knee that helps stabilise the joint by preventing the shin bone from sliding too far forward relative to the thigh bone. "This biological implant promotes faster graft healing and bone integration. While it is a boost for athletes, where long lay-offs often mean muscle loss and mental strain, it can be used on others with ligament tears," said orthopaedic surgeon Arnab Karmakar, who performed the procedure on Thursday. Debraj Das, who had the surgery, is not a professional athlete, but he regularly swims and goes on hikes. He was discharged on Friday. While a section of doctors are sceptical about this new device, which came to India about six months ago, it has been used in the US for a few years now. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like What She Did Mid-Air Left Passengers Speechless medalmerit Learn More Undo "There is not much data available on this device in India, and hence, it will be difficult to assess its merit over conventional reconstruction," said an orthopaedic surgeon from a Kolkata hospital. Karmakar said the bio-absorbable material in the device does not cause allergic reaction as it mimics collagen tissues, which get absorbed and convert into ligament. "The biggest disadvantage is the cost. In the past three to four months, I have used it on around seven patients, including athletes in Odisha," said arthroscopy surgeon Sarthak Patnaik, founder of Sports Science of India, the first sports medicine centre in Odisha.
